Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JCI Insight|June 21, 2019
Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patientsKazushiro Takata, Panos Stathopoulos, Michelangelo Cao, et al.
Annals of the New York Academy of Sciences|November 1, 2003
Antibodies in myasthenia gravis and related disordersAngela Vincent, John McConville, Maria Elena Farrugia, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Scientific Reports|October 27, 2020
Disentangling etiologies of CNS infections in Singapore using multiple correspondence analysis and random forestRaphaël M Zellweger, Sophie Yacoub, Yvonne F Z Chan, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2014
Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopesMichael S Zandi, Ross W Paterson, Mark A Ellul, et al.
Annals of the New York Academy of Sciences|January 30, 2018
Serological and experimental studies in different forms of myasthenia gravisAngela Vincent, Saif Huda, Michelangelo Cao, et al.
Annals of Clinical and Translational Neurology|August 23, 2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravisJae-Yun Lee, Panos Stathopoulos, Sasha Gupta, et al.
Molecular Psychiatry|October 20, 2020
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosisThomas A Pollak, Matthew J Kempton, Conrad Iyegbe, et al.
Brain : a Journal of Neurology|June 23, 2026
Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwideAngela Vincent, Rehab Badi, Nina Barisic, et al.
Pageof 6